Relationship between Subjective Tinnitus Perception and Psychiatric Discomfort.

Relationship between Subjective Tinnitus Perception and Psychiatric Discomfort.
复制标题

DOI:
10.5935/0946-5448.20160015
复制
发表时间:
2017-04-19
期刊:
The international tinnitus journal
影响因子:
--
通讯作者:
Paludetti, Gaetano
Paludetti, Gaetano
中科院分区:
其他
文献类型:
--
作者:
Fetoni, Anna Rita;Lucidi, Daniela;Paludetti, Gaetano

文献摘要

被引文献

相似文献

引言:耳鸣患者有更高的风险发展为焦虑抑郁障碍和生活质量下降。为什么选择的患者能够科普慢性耳鸣的原因,而它代表了其他人的致残症状仍在讨论中。这项研究的目的是确定耳鸣相关的痛苦程度沿着焦虑的流行,罗马天主教大学耳鼻喉科从3月到9月的80名慢性耳鸣患者的抑郁症样本2015.材料和方法:我们对所有患者进行了意大利版耳鸣障碍量表(THI)和医院焦虑和抑郁量表(HADS)。此外,我们调查了患者的不适,听力损失的严重程度和年龄之间的相关性。结果:平均THI评分为40.85,意味着中度不适; 57.5%的患者表现出HADS评分与精神共病的高风险相一致。THI和HADS分数之间显着的线性相关性被证明centered.CONCLUSION:我们建议,患者与严重耳鸣相关的困扰,定期邀请完成心理问卷,以评估神经精神评估和/或具体的药理学规划的可能性。为此,我们建议使用HADS,作为一种可靠和快速的工具。
INTRODUCTION: Tinnitus patients have higher risk of developing anxiety-depressive disorders and decreased quality of life. The reasons why selected patients are able to cope with chronic tinnitus, whereas it represents a disabling symptom for others remain under discussion.OBJECTIVES: the objective of the study was to determine the tinnitus-related degree of distress along with the prevalence of anxiety-depression disorders in a sample of eighty patients referring for chronic tinnitus at the Department of Otolaryngology of Catholic University of Rome from March to September 2015.MATERIALS AND METHODS: We administered to all patients the Italian versions of Tinnitus Handicap Inventory (THI) and Hospital Anxiety and Depression Scale (HADS). Furthermore we investigated the correlation among patient's discomfort, severity of hearing loss and age.RESULTS: Average THI score was 40.85, meaning moderate degree of discomfort; 57.5% of the patients showed HADS scores consistent with high risk of psychiatric comorbidities. A significant linear correlation between THI and HADS scores was demonstrated.CONCLUSION: We suggest that patients with severe tinnitus-related distress are routinely invited to accomplish psychometric questionnaires, to assess the possibility of a neuropsychiatric evaluation and/or specific pharmacological planning. At this purpose we recommend the administration of HADS, as a reliable and quick instrument.